20-F: Visionary Holdings Reports Steep Losses, Pivots to Life Sciences

Visionary Holdings Inc. reported a significant net loss of $15.7 million for fiscal year 2025, driven by declining rental and tuition revenues, and is actively pivoting its business focus to life sciences and AI education.

Summary

• A net loss of $15.7 million was reported for the fiscal year ended March 31, 2025, a substantial decline from the net income of $0.97 million in fiscal 2024.
• Total revenues decreased by 46.2% to $5.0 million in fiscal 2025 from $9.4 million in fiscal 2024.
• Rent revenue decreased by 65.1% to $2.8 million in fiscal 2025, primarily due to the disposal of two subsidiaries with rental buildings and the receivership of two office buildings.
• Tuition revenue decreased by 13.0% to $1.2 million in fiscal 2025, mainly attributed to a decrease in international student numbers at Max the Mutt College of Animation.
• A new business segment, sales of health and wellness nutritional products, generated $1.1 million in revenue in fiscal 2025 with a gross margin of 4.2%.
• Gross profit decreased by 44.4% to $1.4 million in fiscal 2025, although the gross margin slightly increased to 28.0% from 27.1% in the prior year.
• Operating expenses increased by 0.3% to $4.88 million in fiscal 2025, with general and administrative expenses rising by 90.8% due to amortization changes, while professional fees and salaries decreased.
• A significant impairment loss of $4.7 million on property and equipment was recorded due to the receivership of the 95-105 Moatfield Drive properties.
• The company reported a negative working capital of $54.5 million as of March 31, 2025, compared to $67.7 million in fiscal 2024.
• Bank loans totaling $41.4 million from the Bank of China are in default and on demand.
• The company is undergoing a strategic transformation from traditional education and real estate to emerging industries focusing on large health and elderly care, high-end medical aesthetics, and artificial intelligence education.
• Ms. Fan Zhou ceased to be the controlling shareholder on April 15, 2024, transferring her equity interest to a related individual.

Sentiment

Score: 3

Explanation: The company is in a precarious financial position, evidenced by a substantial net loss of $15.7 million, negative working capital of $54.5 million, and defaulted bank loans leading to asset seizure. While the strategic pivot to new industries and future capital raises are outlined, these are forward-looking and carry substantial execution risk, especially given the lack of experienced management in the new fields and identified internal control weaknesses. The current financial state is highly concerning.

Positives

• Successfully transformed into life sciences and AI education, with the life sciences segment generating over $1 million in revenue (20% of total) in fiscal 2025, laying a good foundation for future development.
• Established a new leadership team with experience in the life sciences and high-end medical aesthetics fields.
• Anticipates exponential growth in future revenue from the large health, elderly care, anti-aging, and high-end medical aesthetics industries.
• Management expects the renovation of 95&105 Moatfield Drive into an International Anti-Aging and High-End Medical Aesthetics Health Care Center to generate over CAD $100 million in future revenue and annual revenue exceeding CAD $10 million.
• The AI education project is expected to broaden student enrollment and foster gradual growth in the education business.
• Obtained capital commitments from potential investors for the large health and elderly care, anti-aging, and high-end medical aesthetics projects.
• The gross profit margin for the education service segment increased by 2.3% due to improved operational efficiency and lower staffing costs.
• Secured multiple cooperation agreements for life sciences and AI education initiatives subsequent to the fiscal year end.
• Signed Equity Financing Agreements totaling $11 million and a Loan Agreement for CAD $40 million post-fiscal year end, indicating potential for future funding.

Negatives

• Reported a net loss of $15.7 million in fiscal 2025, a significant reversal from the net income of $0.97 million in fiscal 2024.
• Total revenues declined by 46.2% year-over-year, primarily due to a 65.1% decrease in rent revenue and a 13.0% decrease in tuition revenue.
• Incurred an impairment loss of $4.7 million on property and equipment due to the receivership of the 95-105 Moatfield Drive properties.
• Maintained a negative working capital of $54.5 million as of March 31, 2025, indicating severe liquidity challenges.
• Bank loans totaling $41.4 million from the Bank of China are in default and on demand, leading to the seizure of collateral properties.
• Accrued unpaid income tax liabilities of approximately $1.28 million as of March 31, 2025.
• Management concluded that disclosure controls and procedures were not effective and that the company had not maintained effective internal control over financial reporting due to multiple significant deficiencies and material weaknesses.
• Recorded a loss on disposal of subsidiaries of $368,608 in fiscal 2025.
• Experienced losses on change in fair value on warrants of $1.8 million and convertible debenture of $0.33 million in fiscal 2025.
• High interest expense of $5.0 million in fiscal 2025, significantly impacting profitability.

Risks

• Canada's economic slowdown and tightening international education policies are significantly affecting education program revenues and overseas student enrollment.
• The limited operating history of new education services makes it difficult to predict future prospects and financial performance.
• The downward trend in Canada's real estate industry due to increased bank interest rates poses significant challenges to real estate projects.
• Uncertainty exists regarding the successful completion of new life sciences and real estate projects and the achievement of expected returns, particularly due to the lack of a management team with extensive experience in these new fields.
• There is a risk that future business growth in the life sciences industry may not meet expected goals, as the company is new to this sector and needs to strengthen its understanding of industry policies, management, R&D, and market dynamics.
• Operating and integrating acquired education businesses presents ongoing challenges that could adversely affect operations and financial condition.
• The company needs to develop new industries and innovate financing channels to implement its performance goals and secure necessary funds.
• Compliance with public company rules and evolving corporate governance and public disclosure standards (e.g., Sarbanes-Oxley Act, Nasdaq) may lead to higher costs and divert management's attention.
• Failure to fully address deficiencies in internal control over financial reporting could adversely affect compliance with financial reporting requirements, regulatory filings, and the company's stock price, and impair fraud prevention.
• Foreign currency exchange rate fluctuations between the Canadian dollar and the U.S. dollar may cause volatility in reported gains or losses.
• Non-Canadian citizens may face difficulties enforcing judgments against the company due to its Canadian incorporation and the residency of most directors and assets outside the U.S.
• The loss of key personnel could adversely affect the business, as success depends on the management skills and contacts of directors and senior management.
• Personal information collected is vulnerable to disclosure, theft, or loss, potentially exposing the company to liability or harming its reputation and operations.
• The company may struggle to attract and retain a sufficient number of excellent senior managers, technical professionals, school principals, and qualified teachers, especially in the competitive large health and high-end medical aesthetics industries.
• If the common stock does not qualify for an exemption from penny stock classification, shareholders' ability to sell shares in the secondary market may be restricted.
• The concentration of super voting rights in one person (Ms. Wanhong Wu) may delay or prevent a change in control and could adversely affect the market price of common stock.
• Certain provisions in the amended articles of incorporation, such as the authorization to issue preferred shares, may make an acquisition or change in control more difficult or costly.
• As a foreign private issuer and emerging growth company, the company is exempt from certain U.S. securities rules and reporting requirements, which may provide less protection or information to investors.
• The market price of the common stock may be volatile due to various factors, including operating results, analyst estimates, economic performance, and political conditions.
• The company may be classified as a Passive Foreign Investment Company (PFIC) for U.S. federal income tax purposes, which could result in adverse tax consequences for U.S. holders.
• The current intention not to pay dividends means investment returns will primarily depend on increases in the stock price.
• Indemnification for directors and senior management may negatively impact operating results and financial condition.
• Limited insurance coverage for business and operations exposes the company to significant costs and resource diversion in case of accidents, business interruptions, or natural disasters.
• The company has not adopted a formal cybersecurity risk management plan or established formal processes for assessing cybersecurity risks, which could lead to material impacts from cybersecurity threats.

Future Outlook

The company anticipates exponential revenue growth from its new large health, elderly care, anti-aging, and high-end medical aesthetics industries. It plans to open 6,000 brand franchise stores in Asia within 3 years, aiming for over $100 million annual revenue from health and wellness, and over $100 million annual revenue from anti-aging and medical aesthetics within 2 years. AI education projects are also expected to broaden student enrollment and grow the education business, with management expressing confidence in turning losses into profits and achieving sustained high profits.

Management Comments

• Management has actively addressed the challenges regarding the company's ability to continue operations, mainly by improving the company's liquidity and funding sources through operating cash flow business, equity financing, and renewal of bank loans.
• To fully implement its business plan and maintain sustainable growth, the company is also actively seeking business partners to carry out business and cooperative financing.
• Currently, the company has obtained capital commitments from potential investors for the large health and elderly care, anti-aging, and high-end medical aesthetics projects. This commitment will not only enable the rapid development of our large health and elderly care, anti-aging, and high-end medical aesthetics projects, bringing considerable sustainable revenue to the company, but also bring a historic turning point to the company, enabling it to strongly enter the life sciences emerging industry track and greatly enhance the company's value.
• Our management expects that this initiative [renovating 95&105 Moatfield Drive] may significantly increase its value, generating expected revenue of over CAD $100 million in the future.
• The renovation of 95&105 into an International Anti-Aging and High-End Medical Aesthetics Health Care Center is expected to achieve annual revenue of over 10 million CAD in the future.
• Although the market for this industry is huge, since we have just entered this industry, we need to strengthen our understanding of industry policies, management team, R&D team, and market team. Therefore, there is certain risk whether the future business growth will meet the expected goals.
• We have experienced losses, and there is a high possibility of turning to profitability in the future. The large health and elderly care, high-end medical aesthetics, and life sciences industries are expected to bring us high revenue and profits, enabling us to turn losses into profits as soon as possible and bring us sustained high profits.
• Management expects margin performance to improve gradually as the Company expands its product portfolio, strengthens supplier relationships, and increases sales volumes.
• Management believes that current levels of cash, cash flows from operations and cash flow from bank loans, will be sufficient to meet our anticipated cash needs for at least the next 12 months from the date of this filing.

Industry Context

The Canadian education sector is facing headwinds due to tightening international education policies, which have significantly impacted overseas student enrollment. Concurrently, the Canadian real estate market is experiencing a downturn driven by rising bank interest rates. In response, Visionary Holdings is strategically pivoting towards the large health, elderly care, anti-aging, and high-end medical aesthetics industries, which are identified as emerging sunrise sectors with substantial market potential globally, fueled by an aging population, increased health awareness, and consumption upgrading. Competition in the medical aesthetics market is characterized by technological and service differentiation, brand building, diverse marketing strategies, and strict regulatory oversight.

Comparison to Industry Standards

• The company faces competition in the high-end medical aesthetics market from well-established centers in Canada with over 20 years of operation, which possess long histories, recognized brands, and accumulated market resources.
• In the OSSD education market, competitors include public high schools in Markham (e.g., Markville High School, Unionville High School) and private high schools (e.g., Peoples Christian Academy, J Addison School), which are noted for their long histories, larger campus scales, and excellent teaching facilities.
• The company's Max the Mutt Animation, Art & Design School (MTM) has a history of nearly 30 years and enjoys a high reputation within the Canadian animation industry.

Management Changes

Corporate Governance

Legal Proceedings

• The company originally planned to commence legal proceedings in May 2023 against the seller, general contractor, and subcontractors regarding the parking lot project, seeking reimbursement of excess amounts paid, but has not initiated such proceedings to date.
• Two office buildings located at 95-105 Moatfield Drive, Toronto, were taken over by a receivership appointed by the Ontario Superior Court on August 27, 2024. This action was initiated by the Bank of China due to a default on the loan secured by these properties.

Related Party Transactions

• Ms. Fan Zhou (formerly controlling shareholder, ceased April 15, 2024) periodically advanced funds to support operations; these were unsecured, due on demand, and interest-free. Balances payable to Ms. Fan Zhou were $164,885 as of March 31, 2025, and $3,872 as of March 31, 2024. She also personally guaranteed the bank loan from the Bank of China and a private mortgage at 95 Moatfield. All loans and advances from Ms. Fan Zhou have been substantially repaid as of the report date.
• Katy Liu (employee, CFO) had a two-year loan agreement from April 1, 2023, for a principal balance of $229,706 (C$330,275) plus accrued interest of $64,258 (C$87,000). As of March 31, 2025, the principal balance of $229,706 was outstanding with an interest rate of 20% annually after the maturity date.
• HuiMin Luo (employee) had unsecured, due on demand, and interest-free borrowings from the company, with a balance of $97,273 as of March 31, 2025.
• JunFeng Li (operation manager and minority shareholder of Yuanjian Trillion (GuangZhou) Health Industry Investment Co., Ltd) had unsecured, due on demand, and interest-free borrowings from the company, with a balance of $11,262 as of March 31, 2025.
• Changleshuang Biotechnology (Guangzhou) Limited (49% non-controlling shareholder of Guangzhou Yuanjian) had accounts payable of $1,086,445 for the purchase of products such as probiotics and prebiotics. The cost of products purchased from Changleshuang was $980,915 in fiscal 2025. The settlement period for these products is 8 to 18 months, interest-free.
• XiYong Hou (employee, CEO) had a due from related party balance of $433,507 as of March 31, 2025.
• Kelly Xu (Operation manager and minority shareholder of Lowell Academy) had a due from related party balance of $76,888 as of March 31, 2024. Lowell Academy was not a subsidiary of the company as of March 31, 2025.
• All related party transactions are subject to approval by the Audit Committee of the Board of Directors and are intended to be on terms no less favorable than those obtainable from unaffiliated third parties.

Stakeholder Impact

• Shareholders face significant risks due to the substantial net loss, negative working capital, and defaulted loans, which could lead to further share price volatility and potential dilution from future capital raises. The super-voting rights held by Ms. Wanhong Wu may also impact minority shareholder influence. However, the strategic pivot to life sciences and AI education offers potential for long-term value creation if successful.
• Employees may experience job insecurity due to the company's financial difficulties and strategic shift, although there are plans for recruitment in new business areas and for internal control remediation. Reductions in administrative team budgets have already occurred.
• Education customers (students) may be impacted by strict international student policies affecting enrollment, but could benefit from new AI-assisted learning tools and expanded OSSD programs.
• Customers in the new life sciences segments will gain access to new health and wellness, anti-aging, and high-end medical aesthetics services and products.
• Creditors, particularly the Bank of China, are significantly impacted by defaulted loans and the receivership of properties. Other lenders also face risks from outstanding or defaulted loans, with repayment plans relying on future financing efforts.
• Suppliers, such as Changleshuang Biotechnology, are involved in significant product purchase agreements, with extended interest-free settlement periods, indicating potential credit risk for the company.

Next Steps

• Actively develop the new high-end anti-aging medical beauty business, focusing primarily on the Southeast Asian and North American markets.
• Implement debt restructuring (debt-to-equity swaps), private placement financing, disposal of owned real estate, and borrowings from formerly controlling shareholders to secure sufficient working capital.
• Plan to open 6,000 brand franchise stores for health and wellness projects in Asia within the next 3 years, aiming for annual revenue exceeding $100 million.
• Integrate global resources, technologies, markets, and teams to develop anti-aging and high-end medical aesthetics services, aiming to achieve annual revenue exceeding $100 million in the next 2 years.
• Strengthen the OSSD program by establishing cooperative relationships with more public colleges and universities.
• Build an AI-based comprehensive student management system to track learning journeys and provide personalized tutoring.
• Establish a VR-based virtual teaching laboratory to enhance students' learning experience.
• Develop OSSD Massive Open Online Courses (MOOCs) to provide rich learning content.
• Further expand marketing networks for education programs in target countries, including China, India, Brazil, and Southeast Asia.
• Pay accrued unpaid income tax liabilities in installments starting from January 1, 2026.
• Expect to obtain external financing funds in February 2026 to pay off the default loan from the Bank of China and the private mortgage at 95 Moatfield.
• Remediate internal control deficiencies by developing formal policies, recruiting personnel with relevant expertise, implementing internal control-related applications and systems, establishing proper supporting documentation retention processes, improving inter-departmental communication, strengthening controls over related party transactions, implementing sound budget and cash management systems, updating the corporate governance framework, establishing sound internal controls for bank transaction authorization, and developing review procedures for special and complex transactions.

Key Dates

Recommendation

The company is in a precarious financial position, evidenced by a substantial net loss of $15.7 million, negative working capital of $54.5 million, and defaulted bank loans leading to the receivership of key properties. While the strategic pivot to new industries and future capital raises are outlined, these are forward-looking and carry substantial execution risk, especially given the lack of experienced management in the new fields and identified internal control weaknesses. The reliance on future capital raises and asset disposals to address liquidity issues and debt defaults indicates a high level of uncertainty and financial instability. A seasoned investor would view the current financial health and operational challenges as a strong 'sell' signal, despite the ambitious future plans.

Keywords

Visionary Holdings Inc., SEC filing, 20-F, financial results, net loss, revenue decline, life sciences, medical aesthetics, elderly care, AI education, real estate, Canada, Nasdaq, corporate governance, internal controls, going concern, capital raise, debt default, international education, probiotics, anti-aging, receivership